ALLO vs GILD: Which Stock is Better?
Side-by-side comparison of Allogene Therapeutics Inc and Gilead Sciences Inc in 2026
ALLO
Allogene Therapeutics Inc
$2.15
GILD
Gilead Sciences Inc
$141.11
Key Metrics Comparison
| Metric | ALLO | GILD | Winner |
|---|---|---|---|
| Market Cap | $510.14M | $175.40B | GILD |
| P/E Ratio | N/A | 20.84 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze ALLO
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALLO or GILD a better investment?
Comparing ALLO and GILD: Allogene Therapeutics Inc has a market cap of $510.14M while Gilead Sciences Inc has $175.40B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALLO and GILD?
ALLO (Allogene Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALLO or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALLO or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for ALLO.
Which company is more profitable: ALLO or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for ALLO.
Which is the larger company: ALLO or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $175.40B compared to $510.14M for ALLO.
Should I buy ALLO or GILD in 2026?
Both ALLO and GILD have investment merit. ALLO trades at $2.15 while GILD trades at $141.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALLO and GILD stock?
Key differences: Market Cap ($510.14M vs $175.40B), P/E Ratio (N/A vs 20.8x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).